In a webinar conducted by the National Foundation for Infectious Diseases (NFID), experts gathered to publicly address the ongoing bird flu outbreak across many US states.
From the first known human case in 2022 to the US government pledging nearly $200 million to stop the spread, the H5N1 virus, also known as the bird flu, has evolved into an alarming public health issue in the US. Although an outbreak from human-to-human transmission remains unlikely, representatives from the National Foundation for Infectious Diseases (NFID) and the CDC recently provided an update detailing how the virus has adapted over the past few years and what the public should be aware of as the outbreak continues in US dairy cattle.
To stay up to date on the current bird flu outbreak in the US, be sure to check out the CDC’s website. The NFID’s recent presentation was also published on YouTube for those who want to learn more about the history of the virus up until now. Also be sure to check out our coverage on the bird flu outbreak:
C Difficile Treatment Shows Positive Results in Phase 2 Study
September 5th 2024CRS3123 is a novel, small molecule, antibiotic drug candidate that selectively inhibits 1 form of the bacterial methionyl-tRNA synthetase enzyme and is not affected by resistance to any existing classes of antibiotics.